Extended Data Table 1 Demographic summary of Cohort_1 (SYSUCC-E)

From: The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment

  1. CR, complete remission; PR, partial remission; SD, stable disease.